1. Volume 15, Issue 1, Pages 96-105 (January 2014)
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial 
Fiona Bath-Hextall, PhD, Mara Ozolins, MSc, Sarah J Armstrong, PhD, Graham B Colver, DM, William Perkins, FRCP, Paul S J Miller, PhD, Prof Hywel C Williams, DSc 
The Lancet Oncology 
Volume 15, Issue 1, Pages (January 2014)
DOI: /S (13)
Copyright © 2014 Elsevier Ltd Terms and Conditions

2. Figure
Trial profile
*Numbers who saw the nurse were not available from some smaller centres; an unknown greater number saw a doctor in clinic before assessment; potential participants were directed to the nurse who explained the study. †Non-acceptance by eligible patients. ‡Because of unsuitable histology, death, poor health, regression of basal-cell carcinoma, participant was no longer available for follow-up or was unable to reach. §Excluded from safety analysis. ¶Not known before treatment. ‖Both not serious. **Electrodesiccation and curettage.
The Lancet Oncology  , DOI: ( /S (13) )
Copyright © 2014 Elsevier Ltd Terms and Conditions